首页> 外文期刊>Journal of Diabetes Science and Technology >The Influence of the Smart Glucose Manager Mobile Application on Diabetes Management
【24h】

The Influence of the Smart Glucose Manager Mobile Application on Diabetes Management

机译:智能葡萄糖管理器移动应用程序对糖尿病管理的影响

获取原文
           

摘要

Background: Smartphone use is rapidly growing in developing countries, providing opportunity for development of new health-based mobile applications. The present study investigated the efficacy of a newly designed mobile application, Smart Glucose Manager (SGM), in Sri Lankan patients with diabetes. Methods: A total of 67 patients with access to Android smartphones were randomized into an SGM (n = 27) and a control group (n = 25). Glycosylated hemoglobin (A1c) levels were measured at baseline and every 3 months afterward. The SGM group utilized the application daily, while control-group patients were instructed to continue their standard methods of diabetes management. Independent t -tests were utilized to assess A1c differences at 3 and 6 months postrandomization. A1c improvement, defined as A1c at 6 months minus baseline, was compared with SGM usage to assess effectiveness of diabetic management. Results: At the 6-month follow up, the SGM group had significant lower A1c levels than the control group (7.2% vs 8.17%, P < .0001). For both groups, A1c values decreased from baseline to the 3 months (SGM: 9.52% to 8.16%, P < .0001; control: 9.44% to 8.31%, P < .0001). From 3 months to 6 months, the SGM group showed further improvement of A1c (?0.96% P < .0001), whereas the control group did not ( P = 0.19). A1c improvement was positively correlated with SGM usage ( R = .81, P < .001). Conclusion: The SGM, a mobile application specifically designed to support self-management of diabetes, appeared to show long-term improvement of A1c levels in patients with diabetes residing in Sri Lanka.
机译:背景:发展中国家的智能手机使用量正在迅速增长,这为开发基于健康的新型移动应用程序提供了机会。本研究调查了新设计的移动应用程序智能葡萄糖管理器(SGM)对斯里兰卡糖尿病患者的疗效。方法:将总共67例使用Android智能手机的患者随机分为SGM(n = 27)和对照组(n = 25)。在基线时和之后每3个月测量糖化血红蛋白(A1c)水平。 SGM组每天使用该应用程序,同时指示对照组患者继续其标准的糖尿病管理方法。独立的t检验用于评估随机化后3个月和6个月的A1c差异。将A1c改善(定义为减去基线6个月时的A1c)与SGM使用情况进行比较,以评估糖尿病管理的有效性。结果:在6个月的随访中,SGM组的A1c水平明显低于对照组(7.2%比8.17%,P <.0001)。两组的A1c值均从基线下降至3个月(SGM:9.52%至8.16%,P <.0001;对照组:9.44%至8.31%,P <.0001)。从3个月到6个月,SGM组显示A1c进一步改善(?0.96%P <.0001),而对照组则没有(P = 0.19)。 A1c的改善与SGM的使用呈正相关(R = .81,P <.001)。结论:专门用于支持糖尿病自我管理的移动应用程序SGM似乎显示出斯里兰卡居住的糖尿病患者A1c水平的长期改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号